Takeda

CINRYZE

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Takeda

Cinryze HCPCS:

J0598

HCPCS Code Descriptor:

Injection, c-1 esterase inhibitor (human), cinryze, 10 units

Category:

J Code

Cinryze NDCs:

42227-0083-01

Primary Type:

Immunology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Cinryze CPT Codes:

-96374, 96375, 96375, 99211, 99212, 99213, 99214, 99215 *More information on these CPT codes can be found here https://www.cinryze.com/hcp/reimbursement

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Cinryze:

CINRYZE is an Immunology drug manufactured by Takeda and administered via the Intravenous route of administration. The J Code: J0598 is aligned to the drug CINRYZE.

ACCESS PRICING AND MORE BY REGISTERING

J0598 Added Date:

January 1, 2010

J0598 Effective Date:

January 1, 2011

J0598 Termination Date:

HCPCS Active

Cinryze billing and coding information can be found through Takeda at the link below:
Cinryze patient assistance information can be found through OnePath Patient Support at the URL: https://www.cinryze.com/financial-support
CINRYZE prescribing information can be found at the link below:
Information regarding CINRYZE’s side effects can be found at MedlinePlus